bioMérieux, a global leader in in-vitro diagnostics for over 55 years, develops and produces diagnostic solutions (systems, reagents, software and services) for the diagnosis of infectious diseases.

Through the BioFire Syndromic Approach, clinicians can quickly analyse a broad range of infectious agents with one easy diagnostic test. Our syndromic panels provide comprehensive results in about an hour, making BioFire the right test solution, every time, assisting clinicians with patient management decisions.

Discover our FDA-cleared and CE-marked BioFire® Respiratory 2.1plus Panel, including SARS-CoV 2, BioFire® Gastrointestinal Panel, BioFire® Meningitis/Encephalitis Panel, BioFire® Pneumonia plus Panel, & BioFire® Blood Culture Identification 2 Panel.